Suitability and readability of consumer medical information accompanying prescription medication samples

Lorraine S. Wallace, Amy J. Keenum, Steven E. Roskos, Gregory Blake, Strant T. Colwell, Barry D. Weiss

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objective: To examine readability and formatting characteristics of consumer medication information (CMI) accompanying prescription medication samples. Methods: We collected the most commonly used prescription medication samples (n = 100) from four out-patient clinics at a large teaching hospital in the Southeastern US. Seventeen percent of samples were not pills/tablets and of such diverse nature (e.g., injections, drops, and creams) that there were not enough in any category to draw conclusions. Therefore, our analyses were limited to 83 pill/tablet samples, belonging to 11 drug classes (e.g., cardiovascular, and psychiatric). We noted if CMI was present, and if so we assessed it for how instructions were presented, reading level, text size, format/layout, and comprehensibility. Results: No CMI was present in 39 (46.9%) samples. In 19 (22.9%), CMI was contained in a package insert and in 25 (30.2%) it was printed on the medication package. Average reading difficulty of CMI was at the 10th grade level (range = 6-15) using the Fry formula, and text point size was small (mean 9.9 ± 2.2 on package inserts and 9.4 ± 2.6 when printed on packages). Conclusions: Almost half of samples did not include any type of CMI. For those that had CMI, it was often written at a reading difficulty level higher than the average reading skills of American adults, and the format of most CMI was not optimal for comprehensibility. It is likely that many patients do not understand the instructions accompanying medication samples they receive from clinicians. Practice implications: Clinicians should be cognizant of the shortcomings of CMI accompanying medication samples and thereby, distribute them to patients with caution. Manufacturers too should consider revising CMI to comply with low-literacy guidelines.

Original languageEnglish (US)
Pages (from-to)420-425
Number of pages6
JournalPatient Education and Counseling
Volume70
Issue number3
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Prescriptions
Reading
Product Labeling
Tablets
Teaching Hospitals
Psychiatry
Outpatients
Guidelines
Injections
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Suitability and readability of consumer medical information accompanying prescription medication samples. / Wallace, Lorraine S.; Keenum, Amy J.; Roskos, Steven E.; Blake, Gregory; Colwell, Strant T.; Weiss, Barry D.

In: Patient Education and Counseling, Vol. 70, No. 3, 01.03.2008, p. 420-425.

Research output: Contribution to journalArticle

Wallace, Lorraine S. ; Keenum, Amy J. ; Roskos, Steven E. ; Blake, Gregory ; Colwell, Strant T. ; Weiss, Barry D. / Suitability and readability of consumer medical information accompanying prescription medication samples. In: Patient Education and Counseling. 2008 ; Vol. 70, No. 3. pp. 420-425.
@article{982a4a5f83c84a00af91b5724b2a67d2,
title = "Suitability and readability of consumer medical information accompanying prescription medication samples",
abstract = "Objective: To examine readability and formatting characteristics of consumer medication information (CMI) accompanying prescription medication samples. Methods: We collected the most commonly used prescription medication samples (n = 100) from four out-patient clinics at a large teaching hospital in the Southeastern US. Seventeen percent of samples were not pills/tablets and of such diverse nature (e.g., injections, drops, and creams) that there were not enough in any category to draw conclusions. Therefore, our analyses were limited to 83 pill/tablet samples, belonging to 11 drug classes (e.g., cardiovascular, and psychiatric). We noted if CMI was present, and if so we assessed it for how instructions were presented, reading level, text size, format/layout, and comprehensibility. Results: No CMI was present in 39 (46.9{\%}) samples. In 19 (22.9{\%}), CMI was contained in a package insert and in 25 (30.2{\%}) it was printed on the medication package. Average reading difficulty of CMI was at the 10th grade level (range = 6-15) using the Fry formula, and text point size was small (mean 9.9 ± 2.2 on package inserts and 9.4 ± 2.6 when printed on packages). Conclusions: Almost half of samples did not include any type of CMI. For those that had CMI, it was often written at a reading difficulty level higher than the average reading skills of American adults, and the format of most CMI was not optimal for comprehensibility. It is likely that many patients do not understand the instructions accompanying medication samples they receive from clinicians. Practice implications: Clinicians should be cognizant of the shortcomings of CMI accompanying medication samples and thereby, distribute them to patients with caution. Manufacturers too should consider revising CMI to comply with low-literacy guidelines.",
author = "Wallace, {Lorraine S.} and Keenum, {Amy J.} and Roskos, {Steven E.} and Gregory Blake and Colwell, {Strant T.} and Weiss, {Barry D.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.pec.2007.11.017",
language = "English (US)",
volume = "70",
pages = "420--425",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Suitability and readability of consumer medical information accompanying prescription medication samples

AU - Wallace, Lorraine S.

AU - Keenum, Amy J.

AU - Roskos, Steven E.

AU - Blake, Gregory

AU - Colwell, Strant T.

AU - Weiss, Barry D.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Objective: To examine readability and formatting characteristics of consumer medication information (CMI) accompanying prescription medication samples. Methods: We collected the most commonly used prescription medication samples (n = 100) from four out-patient clinics at a large teaching hospital in the Southeastern US. Seventeen percent of samples were not pills/tablets and of such diverse nature (e.g., injections, drops, and creams) that there were not enough in any category to draw conclusions. Therefore, our analyses were limited to 83 pill/tablet samples, belonging to 11 drug classes (e.g., cardiovascular, and psychiatric). We noted if CMI was present, and if so we assessed it for how instructions were presented, reading level, text size, format/layout, and comprehensibility. Results: No CMI was present in 39 (46.9%) samples. In 19 (22.9%), CMI was contained in a package insert and in 25 (30.2%) it was printed on the medication package. Average reading difficulty of CMI was at the 10th grade level (range = 6-15) using the Fry formula, and text point size was small (mean 9.9 ± 2.2 on package inserts and 9.4 ± 2.6 when printed on packages). Conclusions: Almost half of samples did not include any type of CMI. For those that had CMI, it was often written at a reading difficulty level higher than the average reading skills of American adults, and the format of most CMI was not optimal for comprehensibility. It is likely that many patients do not understand the instructions accompanying medication samples they receive from clinicians. Practice implications: Clinicians should be cognizant of the shortcomings of CMI accompanying medication samples and thereby, distribute them to patients with caution. Manufacturers too should consider revising CMI to comply with low-literacy guidelines.

AB - Objective: To examine readability and formatting characteristics of consumer medication information (CMI) accompanying prescription medication samples. Methods: We collected the most commonly used prescription medication samples (n = 100) from four out-patient clinics at a large teaching hospital in the Southeastern US. Seventeen percent of samples were not pills/tablets and of such diverse nature (e.g., injections, drops, and creams) that there were not enough in any category to draw conclusions. Therefore, our analyses were limited to 83 pill/tablet samples, belonging to 11 drug classes (e.g., cardiovascular, and psychiatric). We noted if CMI was present, and if so we assessed it for how instructions were presented, reading level, text size, format/layout, and comprehensibility. Results: No CMI was present in 39 (46.9%) samples. In 19 (22.9%), CMI was contained in a package insert and in 25 (30.2%) it was printed on the medication package. Average reading difficulty of CMI was at the 10th grade level (range = 6-15) using the Fry formula, and text point size was small (mean 9.9 ± 2.2 on package inserts and 9.4 ± 2.6 when printed on packages). Conclusions: Almost half of samples did not include any type of CMI. For those that had CMI, it was often written at a reading difficulty level higher than the average reading skills of American adults, and the format of most CMI was not optimal for comprehensibility. It is likely that many patients do not understand the instructions accompanying medication samples they receive from clinicians. Practice implications: Clinicians should be cognizant of the shortcomings of CMI accompanying medication samples and thereby, distribute them to patients with caution. Manufacturers too should consider revising CMI to comply with low-literacy guidelines.

UR - http://www.scopus.com/inward/record.url?scp=39149099974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149099974&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2007.11.017

DO - 10.1016/j.pec.2007.11.017

M3 - Article

VL - 70

SP - 420

EP - 425

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 3

ER -